LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 7.66 | 770.25 | 1087 | 1090 | 0.9973 | 0.9890 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 10.06 | 770.25 | 1128 | 1218 | 0.9257 | 0.7798 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 10.06 | 770.25 | 1165 | 1218 | 0.9561 | 0.8688 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 10.06 | 770.25 | 1163 | 1218 | 0.9545 | 0.8640 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 12.28 | 770.25 | 1227 | 1358 | 0.9035 | 0.7666 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 12.28 | 770.25 | 1252 | 1358 | 0.9219 | 0.8107 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 12.28 | 770.25 | 1230 | 1358 | 0.9057 | 0.7719 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 14.50 | 770.25 | 1325 | 1497 | 0.8850 | 0.7607 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 14.50 | 770.25 | 1177 | 1497 | 0.7861 | 0.5561 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 14.50 | 770.25 | 1240 | 1497 | 0.8282 | 0.6431 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 16.73 | 770.25 | 1338 | 1664 | 0.8038 | 0.6434 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 16.73 | 770.25 | 1312 | 1664 | 0.7882 | 0.6146 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 16.73 | 770.25 | 1301 | 1664 | 0.7816 | 0.6024 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 18.95 | 770.25 | 1356 | 1832 | 0.7400 | 0.5720 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 18.95 | 770.25 | 1254 | 1832 | 0.6843 | 0.4767 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 18.95 | 770.25 | 1263 | 1832 | 0.6892 | 0.4851 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 21.17 | 770.25 | 1397 | 2008 | 0.6956 | 0.5382 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 21.17 | 770.25 | 1225 | 2008 | 0.6100 | 0.3988 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 21.17 | 770.25 | 1310 | 2008 | 0.6523 | 0.4683 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 23.39 | 770.25 | 1439 | 2244 | 0.6411 | 0.4994 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 23.39 | 770.25 | 1299 | 2244 | 0.5788 | 0.4031 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 23.39 | 770.25 | 1339 | 2244 | 0.5966 | 0.4310 | MN20160304_L02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 25.62 | 770.25 | 1374 | 2514 | 0.5464 | 0.4036 | MN20160304_L02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 25.62 | 770.25 | 1292 | 2514 | 0.5137 | 0.3539 | MN20160304_L02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 25.62 | 770.25 | 1387 | 2514 | 0.5515 | 0.4114 | MN20160304_L02 | N17 |